Cargando…

Hantavirus Infections—Treatment and Prevention

PURPOSE OF REVIEW: Hantavirus infection is an emerging zoonosis and there are two main clinical presentations, hemorrhagic fever with renal syndrome (HFRS) and Hantavirus pulmonary syndrome (HPS). Although Hantavirus infections have a worldwide distribution with a high mortality rate, a safe and eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dheerasekara, Kalpa, Sumathipala, Saranga, Muthugala, Rohitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Viral Infections (N Malavige, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594967/ https://www.ncbi.nlm.nih.gov/pubmed/33144850 http://dx.doi.org/10.1007/s40506-020-00236-3

Ejemplares similares

Discovering Drugs for the Treatment of Ebola Virus
por: Bixler, Sandra L., et al.
Publicado: (2017)

Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever
por: Bifani, Amanda Makha, et al.
Publicado: (2020)

Vaccination and Therapeutics: Responding to the Changing Epidemiology of Yellow Fever
por: Bifani, Amanda Makha, et al.
Publicado: (2020)

Japanese Encephalitis Vaccines
por: Satchidanandam, Vijaya
Publicado: (2020)

The pattern of cytomegalovirus replication in post-renal transplant recipients with pre-emptive therapy strategy during the 1(st) year of post-transplantation
por: Dheerasekara, Kalpa, et al.
Publicado: (2023)

Impact of a Comprehensive SARS-CoV-2 Infection Prevention Bundle on Rates of Hospital-Acquired Respiratory Viral Infections
por: Seidelman, Jessica, et al.
Publicado: (2021)

COVID-19: management and infection control
por: Harte, Jeffrey, et al.
Publicado: (2021)

Influenza: epidemiology and hospital management
por: Tyrrell, Carina SB., et al.
Publicado: (2021)

The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
por: Kandeel, Amr, et al.
Publicado: (2016)

Aerosol-Transmitted Infections—a New Consideration for Public Health and Infection Control Teams
por: Tang, Julian W., et al.
Publicado: (2015)

Hypogonadism in the HIV-Infected Man
por: Wong, Nicholas, et al.
Publicado: (2017)

Cytomegalovirus Treatment
por: Tan, Ban Hock
Publicado: (2014)

Japanese Surveillance Systems and Treatment for Influenza
por: Zaraket, Hassan, et al.
Publicado: (2016)

Seasonal Human Influenza: Treatment Options
por: Rowe, Emily, et al.
Publicado: (2014)

Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment
por: Gan, Victor C.
Publicado: (2014)

Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: How Close Are We?
por: Omrani, Ali S., et al.
Publicado: (2015)

Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections
por: Vergote, Valentijn, et al.
Publicado: (2021)

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
por: Martin, Natasha K, et al.
Publicado: (2013)

Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection
por: Lattimore, Sam, et al.
Publicado: (2014)

Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy
por: Osiowy, Carla, et al.
Publicado: (2016)

The Role of Clinical Virology Laboratory and the Clinical Virology Laboratorian in Ensuring Effective Surveillance for Influenza and Other Respiratory Viruses: Points to Consider and Pitfalls to Avoid
por: Drews, Steven J.
Publicado: (2016)

Next-Generation Sequencing Sheds Light on the Natural History of Hepatitis C Infection in Patients Who Fail Treatment
por: Abdelrahman, Tamer, et al.
Publicado: (2015)

Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients
por: Chayama, Kazuaki, et al.
Publicado: (2015)

Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single‐arm, open‐label, phase 3 trial
por: Gao, Yanhang, et al.
Publicado: (2020)

Hepatitis C virus transmission among human immunodeficiency virus‐infected men who have sex with men: Modeling the effect of behavioral and treatment interventions
por: Salazar‐Vizcaya, Luisa, et al.
Publicado: (2016)

Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2020)

Flunarizine prevents hepatitis C virus membrane fusion in a genotype‐dependent manner by targeting the potential fusion peptide within E1
por: Perin, Paula M., et al.
Publicado: (2015)

Neutrophil induced T-cell apoptosis during a viral infection
por: Haagmans, Bart L., et al.
Publicado: (1997)

Acute hemorrhagic pancreatitis following influenza infection: a case report
por: Wickramasinghe, Chathula Ushari, et al.
Publicado: (2023)

Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implications
por: Cuadros, Diego F, et al.
Publicado: (2014)

Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt
por: Benova, Lenka, et al.
Publicado: (2015)

Aspects of slow and persistent virus infections Proceedings of the European Worshop sponsored by the Commission of the European Communities on the advice of the Committee on Medical and Public Health Research, held in London (U:K:), April 5-6, 1979.
Publicado: (1979)

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans
por: Kelly, Christabel, et al.
Publicado: (2016)

DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
por: Burza, Maria Antonella, et al.
Publicado: (2015)

Interaction of TLR–IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese
por: He, Dengming, et al.
Publicado: (2015)

Histological changes in HCV antibody–positive, HCV RNA–negative subjects suggest persistent virus infection
por: Hoare, Matthew, et al.
Publicado: (2008)

Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection
por: Robinson, Mark W., et al.
Publicado: (2015)

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
por: Poordad, Fred, et al.
Publicado: (2016)

Transcriptome Sequencing, Microarray, and Proteomic Analyses Reveal Cellular and Metabolic Impact of Hepatitis C Virus Infection In Vitro
por: Woodhouse, Stephen D, et al.
Publicado: (2010)

Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens
por: Reddy, K. Rajender, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r821btfkpsja6k1dj93rma2kb8